Finance

Beta
Lists
NEPHROPLUS:NSE
Nephrocare Health Services Ltd
₹734.95
-1.10%
(-8.15) 1D
Jun 17, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NEPHROPLUS...
Open
₹746.00
High
₹747.00
Low
₹720.65
Mkt. cap
73.78B
Avg. vol.
291.34K
Volume
112.98K
P/E ratio
90.73
52-wk high
₹769.75
52-wk low
₹446.00
EPS
₹8.10
No. of employees
3K
Open
₹746.00
High
₹747.00
Low
₹720.65
Mkt. cap
73.78B
Avg. vol.
291.34K
Volume
112.98K
P/E ratio
90.73
52-wk high
₹769.75
52-wk low
₹446.00
EPS
₹8.10
No. of employees
3K
News stories
From sources across the web
About Nephrocare Health Services Ltd
CEO-
Employees3.45K
Founded2009
Headquarters-
SectorHealth care provider
Websitenephroplus.com
Last report
May 20, 2026
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
2.66B / 2.65B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.37B
2.37B
2.60B
2.66B
Cost of goods sold
1.48B
1.48B
1.52B
1.56B
Cost of revenue
1.48B
1.48B
1.52B
1.56B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
56.22M
56.22M
-
-
Operating expense
536.82M
536.82M
684.30M
816.07M
Total operating expenses
2.02B
2.02B
2.21B
2.38B
Operating income
349.68M
349.68M
390.04M
279.23M
Other non operating income
-3.46M
-3.46M
33.16M
115.69M
EBT including unusual items
139.46M
139.46M
363.60M
332.19M
EBT excluding unusual items
135.88M
135.88M
363.60M
332.19M
Income tax expense
68.32M
68.32M
41.20M
28.49M
Effective tax rate
48.99%
48.99%
11.33%
8.58%
Other operating expenses
271.69M
271.69M
465.69M
557.62M
Net income
71.14M
71.14M
322.40M
303.70M
Net profit margin
3.00%
3.00%
12.41%
11.43%
Earnings per share
-
-
-
-
Interest and investment income
24.24M
24.24M
-
-
Interest expense
-251.32M
-251.32M
-59.60M
-31.80M
Net interest expenses
-227.08M
-227.08M
-59.60M
-31.80M
Depreciation and amortization charges
208.90M
208.90M
218.61M
258.45M
EBITDA
521.27M
521.27M
561.64M
505.90M
Gain or loss from assets sale
1.12M
1.12M
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer